AbbVie yesterday announced the 40 outstanding students with cystic fibrosis (CF) who will each receive $2,500 to pursue their undergraduate or graduate school education during the 2014-2015 school year through the AbbVie CF Scholarship program. Voting for two of the 40 winners to earn the title of 2014 Thriving Undergraduate or Graduate Scholar is now open to the public at www.AbbVieCFScholarship.com until September 15.
Following their announcement to open a bioscience center in Chicago for their research, clinical and regulatory staff, Marathon Pharmaceuticals announced Babar Ghias has joined the company as vice president of corporate development.
Digital health incubator Rock Health has teamed up with three new corporate entities – Blue Shield of California, Deloitte and global healthcare firm Abbott.
Medical device companies are having a much harder time raising early-stage venture capital than biotech and pharma, according to a recent Silicon Valley Bank report.
“On the Series A side of things, biotech is a pretty stable area right now, but devices have some significant issues in trying to find ventures to support Series A company creation,” said Jonathon Norris, the author of “Trends in Healthcare: Investments and Exits.”
The US Food and Drug Administration has granted tentative approval for the use of Eli Lilly/Boehringer Ingelheim’s biosimilar insulin Basaglar, for long-lasting control of blood sugar levels in patients with diabetes in between meals and during the night.
Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven’t caught on with the biggest pharmaceutical companies.
Ever since the FDA drafted a set of rules for biosimilars in 2012, a debate has been raging over whether those drugs should carry the same generic names as the products they emulate. Now, some doctors are weighing in on the issue, urging the FDA to require biosimilars to have different names than branded biotech drugs.
Italian soccer leagues have been at the forefront of promoting automated external defibrillators (AEDs) at sporting events ever since 2012 when Piermario Morosini, a 25-year-old midfielder for Livorno, suffered sudden cardiac arrest (SCA) during a match and died.
This article originally appeared on VentureBeat
I met Kathryn Gould longer ago than either of us want to admit.
Kathryn has been the founding VP of Marketing of Oracle, a successful recruiter, a world class venture capitalist, a co-founder of a venture capital firm, a great board member, one of my mentors and most importantly a wonderful friend.